Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,610 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07765927Recruiting
Exercise program for people with breast or gynecologic cancer
This study is testing whether an exercise program for people with breast or gynecologic cancer is feasible to run. It aims to see if patients can participate and follow the program.
Iowa City, IowaAges 18 years+ - NCT07766395Recruiting
Daily powder for women's wellness and fitness
This trial tests a daily powder supplement designed to support lean muscle, hormone balance, digestion, and skin, hair, and nail health. If you're an active woman with some common wellness concerns, this study may help you see if the supplement makes a difference.
Las Vegas, NevadaAges 21–45 - NCT07764796Recruiting
Mobile health support for breast cancer screening in Kenya
This study tests a mobile health program that helps women in Nairobi, Kenya get screened for breast cancer earlier. It aims to guide women through the screening process and connect them with the right care.
Atlanta, GeorgiaAges 18 years+ - NCT06573983Recruiting
Fall prevention program for older veterans
This study aims to improve fall prevention for older veterans. It tests a program that combines telehealth check-ins with a caregiver-supported physical assessment to reduce fall risk. Participation may help you feel safer and more stable.
Aurora, ColoradoAges 65 years+ - NCT07333053Recruiting
Chemotherapy through a catheter for advanced colorectal cancer
This trial tests giving chemotherapy directly into the artery that feeds the tumor, which may help control advanced colorectal cancer that cannot be removed with surgery. It is for people who have not yet had other treatments and whose main tumor is in the colon or rectum.
Xicheng, Beijing MunicipalityAges 18 years+ - NCT07463209Recruiting
Diabetes education with continuous glucose monitoring for older adults
This study tests whether adding continuous glucose monitoring (CGM) to diabetes education helps older adults with diabetes manage their blood sugar better. You and a care partner will learn how to use CGM and support each other.
Chapel Hill, North CarolinaAges 65 years+ - NCT07351058RecruitingPhase 3
Enicepatide for weight loss in people with type 2 diabetes
This trial tests an investigational medication, Enicepatide, to see if it helps people with obesity or overweight and type 2 diabetes lose weight and improve blood sugar control. You will receive weekly injections and regular check-ups.
Guntersville, AlabamaAges 18 years+ - NCT07760792Recruiting
Bacteria on ureteral stents: risks and impact
This study looks at whether bacteria grow on the temporary tube placed in your ureter (the tube that carries urine from your kidney to your bladder) during treatment. It aims to understand what problems this might cause and how it affects your recovery.
CairoAges 18 years+ - NCT06843447RecruitingPhase 1/Phase 2
Study of Raludotatug Deruxtecan for Ovarian Cancer
This study tests a new drug called raludotatug deruxtecan for people with ovarian cancer that has come back. It's designed for those whose cancer is either sensitive or resistant to platinum chemotherapy, and who have had 1-3 prior treatments.
New Haven, ConnecticutAges 18 years+ - NCT06975306Recruiting
Bone Graft for Kneecap Defect in ACL Surgery
This study looks at how a bone graft used to fill a gap in the kneecap affects healing and recovery after ACL reconstruction. Researchers want to see if the graft helps the bone heal better and improves your knee function.
Phoenix, ArizonaAges 18–40 - NCT06447597RecruitingPhase 2/Phase 3
Study of B007 for Generalized Myasthenia Gravis
This trial tests a new drug called B007 for people with generalized myasthenia gravis who have specific antibodies and moderate to severe muscle weakness. It aims to see if the drug can improve daily activities and reduce symptoms.
BeijingAges 18–70 - NCT07519772RecruitingPhase 1/Phase 2
Testing MK-1045 for Hard-to-Treat Lymphoma
This study tests a new drug called MK-1045 for people with follicular lymphoma or diffuse large B-cell lymphoma (two types of blood cancer) that hasn't responded to at least two previous treatments. The drug is designed to target cancer cells and may help people whose cancer has come back or stopped responding to therapy.
Denver, ColoradoAges 18 years+ - NCT07351045RecruitingPhase 3
Study of enicepatide for weight loss in obesity or overweight
This study tests a new injectable medication called enicepatide for people with obesity or overweight who have not been able to lose weight through diet and exercise alone. It may help you lose weight and improve health conditions linked to excess weight.
Anniston, AlabamaAges 18 years+ - NCT06374498Enrolling by invitation
Looking inside heart arteries to improve stent placement
This study tests a new imaging technique to help doctors see inside your heart arteries during a stent procedure. It may help guide treatment and improve outcomes for people with heart disease.
Boston, MassachusettsAges 18 years+ - NCT07348237RecruitingPhase 1
Testing a new kidney disease drug in patients with kidney failure
This trial tests the safety of a new medicine (MK-2828) in people with advanced kidney disease or on dialysis, and compares them to healthy volunteers. The goal is to understand how the drug works in the body and if it's safe for these patients.
Miami Lakes, FloridaAges 24–85 - NCT06381115Recruiting
SleepWell24 app for new CPAP users
This study tests a smartphone app called SleepWell24 to help people with newly diagnosed sleep apnea stick with their CPAP therapy and improve their quality of life.
Scottsdale, ArizonaAges 18 years+ - NCT07033494RecruitingPhase 2
Study of MK-2214 for early Alzheimer's disease
This trial tests an experimental medicine called MK-2214 for people with early Alzheimer's (mild cognitive impairment or mild dementia). The goal is to see if it can slow memory and thinking problems.
Irvine, CaliforniaAges 50–85 - NCT07764081Recruiting
Coronary artery aneurysm care and outcomes
This study looks at how coronary artery aneurysms (a bulging or ballooning of the heart's blood vessel wall) are managed and how they affect people over time. It aims to improve future care by tracking treatment and health results.
Nanjing, JiangsuAges 18–80 - NCT07027345RecruitingPhase 2
Topical TolaSure cream for epidermolysis bullosa simplex
This study tests a medicated cream called TolaSure on skin affected by epidermolysis bullosa simplex (EBS), a condition that causes fragile skin and blistering. The cream aims to reduce blistering and improve healing by targeting a faulty protein in the skin. It is for people with localized, intermediate, or severe EBS who are currently having active blistering.
Palo Alto, CaliforniaAges 2 years+ - NCT07764172Recruiting
Sarcopenia in acute ischemic stroke
This study looks at muscle loss (sarcopenia) in people who have had an acute ischemic stroke. It aims to understand how muscle wasting affects recovery, which may help improve care for stroke patients.
MoscowAges 50 years+ - NCT07317700RecruitingPhase 3
Study of a new pill for high-risk myelofibrosis
This trial is testing a new pill for people with intermediate or high-risk myelofibrosis, a type of bone marrow cancer. It aims to see if the drug can help manage the disease and offer a new treatment option for those who may have limited choices.
Chengdu, SichuanAges 18–80 - NCT07029997Recruiting
Follow-up study of the Solo+ ear tube device
This study checks how well the Solo+ ear tube device works over time. If you or your child had the device placed to help with ear infections or fluid buildup, joining helps doctors learn how it performs.
Trieste, Trieste (TS)Ages 6 months+ - NCT06318533RecruitingEarly Phase 1
Engineered immune cell therapy for autoimmune diseases
This early-stage study tests an experimental treatment that uses engineered immune cells (called CAR natural killer cells) to calm overactive immune responses in people with moderate to severe autoimmune diseases that have not fully responded to standard treatments. It aims to offer a new option for patients who have not gotten enough benefit from usual therapies.
Zhenjiang, JiangsuAges 18–70 - NCT07624786Recruiting
Study of How Breathing Tubes and Patients Work Together
This study looks at recordings from patients on breathing machines (ventilators) in the hospital to understand when the machine and patient's breathing don't sync up, and whether this affects how well patients do. Researchers will review your medical records and machine data that were already collected during your hospital stay.
Eindhoven, North BrabantAges 18 years+
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,610 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.